Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/1998
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998040486A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998DE19719652A1 Use of tissue factor
12/03/1998CA2293703A1 Disinfecting compositions and processes for disinfecting surfaces
12/03/1998CA2292877A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998CA2292876A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998CA2291774A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291750A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291728A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291709A1 Novel angiogenesis inhibitors
12/03/1998CA2291489A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998CA2291251A1 Novel process
12/03/1998CA2291235A1 Cyanoamidines as cell proliferation inhibitors
12/03/1998CA2289037A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998CA2288317A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo¬3,2-d|pyrimidin-4-ones
12/03/1998CA2288235A1 Tumour suppressor gene dbccr1 at 9q32-33
12/02/1998EP0880533A1 Triazole derivatives useful in therapy
12/02/1998EP0880362A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
12/02/1998EP0880353A1 Compositions and methods for modulating melanin production
12/02/1998CN1200280A Quick-action liquid medicine for treating burn
12/01/1998US5844004 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843947 N-pyridyl carboxamides and derivatives
12/01/1998US5843943 Compounds for inhibition of ceramide-mediated signal transduction
12/01/1998US5843936 Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes
12/01/1998US5843935 Protein kinase C inhibitors
12/01/1998US5843932 Therapeutic methods and delivery systems utilizing sex steroid precursors
12/01/1998US5843927 18,19-dinor-vitamin D compounds
12/01/1998US5843926 Use of salicyclic acid for regulating skin wrinkles and/or skin atrophy
12/01/1998US5843910 Colchicine derivatives and the therapeutical use thereof
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
11/1998
11/26/1998WO1998053051A1 Short peptides which selectively modulate intracellular signalling
11/26/1998WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998WO1998052948A1 Compounds for inhibition of ceramide-mediated signal transduction
11/26/1998WO1998052942A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998WO1998052941A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
11/26/1998WO1998052940A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/26/1998WO1998052937A2 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
11/26/1998WO1998052915A2 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists
11/26/1998WO1998052914A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998WO1998052894A1 Cyclohexanediol derivatives
11/26/1998WO1998052576A1 Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
11/26/1998WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/26/1998WO1998052553A1 Methods for treatment of conditions associated with lactosylceramide
11/26/1998WO1998052518A1 Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof
11/26/1998WO1998036733A3 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/26/1998WO1998020834A3 Method for treatment of dermatological disorders
11/26/1998DE19722848A1 Leukotrien-B¶4¶-Derivate, insbesondere Oximo-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular oximo-LTB¶4¶ antagonists
11/26/1998CA2294804A1 Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof
11/26/1998CA2291123A1 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists
11/26/1998CA2291115A1 Substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2291112A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998CA2291111A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998CA2290825A1 Short peptides which selectively modulate intracellular signalling
11/26/1998CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998CA2288787A1 Pyrazole derivatives as p38 kinase inhibitors
11/26/1998CA2288741A1 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2288629A1 Cyclohexanediol derivatives
11/26/1998CA2287484A1 Compounds for inhibition of ceramide-mediated signal transduction
11/25/1998EP0879814A1 Triaromatic compounds, compositions containing them and uses thereof
11/25/1998EP0879589A1 Nanoemulsions based on non-ionic amphiphilic lipids aminated silicones and their use
11/25/1998EP0633789B1 Wound dressing, wound plaster or carrier matrix
11/25/1998EP0624159B1 Pyridyl substituted imidazoles
11/25/1998CN1200030A Topical compositions having improved skin feel
11/25/1998CN1199640A Chinese medicine liquid for eliminating acne and skin care
11/24/1998US5840846 Fibronectin binding protein as well as its preparation
11/24/1998US5840735 Estrogen
11/24/1998US5840717 Use of salysylic acid for regulating skin wrinkles and/or skin atrophy
11/24/1998US5840712 Water soluble vitamin B12 receptor modulating agents and methods related thereto
11/24/1998US5840701 Antiischemic agents and macomolecules
11/24/1998US5840695 Ectoparasite saliva proteins and apparatus to collect such proteins
11/24/1998US5840311 Administering hepatocyte growth factors to treat fibrosis disorder; increases collagenase activity
11/24/1998US5840299 Binding and treatment of multiple sclerosis
11/24/1998US5840283 Composition and method for treating diseased nails
11/24/1998US5840277 Treatment of chronic pulmonary inflammation
11/24/1998CA2029705C Enzymatic resolution of endo-bicyclo¬2.2.1|heptan-2-ol and derived pharmaceutical agents
11/22/1998CA2231017A1 A member of the frzb family, frazzled
11/19/1998WO1998051679A1 Tocopherol esters and their cosmetic and pharmaceutical uses
11/19/1998WO1998051678A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
11/19/1998WO1998051662A2 Compounds and methods for the inhibition of the expression of vcam-1
11/19/1998WO1998051346A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
11/19/1998WO1998051321A1 Tissue factor for influencing blood vessel formation
11/19/1998WO1998051289A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998WO1998051277A1 Medical uses of pyruvates
11/19/1998WO1998040086A3 Essential oil composition
11/19/1998WO1998031802A3 Secreted proteins and polynucleotides encoding them
11/19/1998DE19720339A1 Treatment or prevention of undesired skin pigmentation
11/19/1998CA2428130A1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998CA2290067A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
11/19/1998CA2289704A1 Medical uses of pyruvates
11/19/1998CA2288117A1 Tissue factor for influencing blood vessel formation
11/18/1998EP0877804A1 Inhibitors of cell-cycle progression, and uses related thereto
11/18/1998EP0877748A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/18/1998EP0877743A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1998EP0877619A1 Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract
11/18/1998EP0696312B1 Process for obtaining high-purity egg oil and use thereof
1 ... 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 ... 1065